Arcadia Biosciences Inc
RKDA4.345USD
+0.135+3.21%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
5.94MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Arcadia Biosciences Inc Unternehmen
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola). Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (Non-GMO) project verified and only contains 60 calories per serving. It offers Zola in different varieties, such as Original, Slightly Sweetened; Original with Pulp, Slightly Sweetened; Espresso, Slightly Sweetened; Pineapple; Lime; and others. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls.
Unternehmensinformationen
BörsenkürzelRKDA
Name des UnternehmensArcadia Biosciences Inc
IPO-datumMay 15, 2015
CEOMr. Thomas J. Schaefer
Anzahl der mitarbeiter9
WertpapierartOrdinary Share
GeschäftsjahresendeMay 15
Addresse202 Cousteau Place
StadtDAVIS
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl95618
Telefon15307567077
Websitehttps://arcadiabio.com/
BörsenkürzelRKDA
IPO-datumMay 15, 2015
CEOMr. Thomas J. Schaefer
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark Kawakami
Mr. Mark Kawakami
Chief Financial Officer
Chief Financial Officer
2.68K
--
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Deborah (Debbie) Carosella
Ms. Deborah (Debbie) Carosella
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark Kawakami
Mr. Mark Kawakami
Chief Financial Officer
Chief Financial Officer
2.68K
--
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Deborah (Debbie) Carosella
Ms. Deborah (Debbie) Carosella
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
4.90M
97.19%
Canada
109.00K
2.16%
Argentina
26.00K
0.52%
India
7.00K
0.14%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, May 17
Aktualisiert: Sat, May 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Mariner Wealth Advisors
2.01%
The Vanguard Group, Inc.
1.03%
Geode Capital Management, L.L.C.
0.94%
State Street Global Advisors (US)
0.89%
UBS Financial Services, Inc.
0.62%
Other
94.51%
Aktionäre
Aktionäre
Anteil
Mariner Wealth Advisors
2.01%
The Vanguard Group, Inc.
1.03%
Geode Capital Management, L.L.C.
0.94%
State Street Global Advisors (US)
0.89%
UBS Financial Services, Inc.
0.62%
Other
94.51%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
3.68%
Investment Advisor/Hedge Fund
1.84%
Individual Investor
0.82%
Research Firm
0.06%
Hedge Fund
0.03%
Other
93.57%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
35
87.93K
6.43%
-233.63K
2025Q1
38
87.93K
6.43%
-244.41K
2024Q4
49
156.69K
11.48%
-110.76K
2024Q3
49
100.21K
9.85%
-202.17K
2024Q2
47
71.82K
7.77%
-229.97K
2024Q1
51
258.53K
25.32%
-38.12K
2023Q4
56
321.69K
30.80%
+98.94K
2023Q3
62
165.26K
19.23%
-273.71K
2023Q2
66
255.84K
27.41%
-81.95K
2023Q1
69
274.06K
33.25%
+123.06K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Mariner Wealth Advisors
27.48K
2.01%
+2.48K
+9.92%
Mar 31, 2025
The Vanguard Group, Inc.
14.04K
1.03%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
12.79K
0.94%
+498.00
+4.05%
Mar 31, 2025
State Street Global Advisors (US)
12.15K
0.89%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
8.53K
0.62%
-5.38K
-38.71%
Mar 31, 2025
Jacot (Stanley Jr)
5.00K
0.37%
--
--
Mar 31, 2025
Schaefer (Thomas J.)
2.82K
0.21%
--
--
Mar 31, 2025
Kawakami (Mark)
2.68K
0.2%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
606.00
0.04%
--
--
Mar 31, 2025
Comcowich (Kevin J.)
500.00
0.04%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Datum
Art
Verhältnis
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
